Chronic and recurrent meningitis

Practical Neurology

Volumn 8, Issue 6, 2008, Pages 348-361

  Ginsberg, Lionel ^a   Kidd, Desmond ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CHRONIC DISEASE; CLINICAL PROTOCOL; COMMUNICABLE DISEASE; DECISION TREE; DIFFERENTIAL DIAGNOSIS; HUMAN; INFLAMMATION; MENINGITIS; MICROBIOLOGY; RECURRENT DISEASE; REVIEW; STANDARD;

ALGORITHMS; CHRONIC DISEASE; CLINICAL PROTOCOLS; COMMUNICABLE DISEASES; DECISION TREES; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFLAMMATION; MENINGITIS; RECURRENCE;

EID: 56849131860     PISSN: 14747758     EISSN: 14747766     Source Type: Journal    
DOI: 10.1136/jnnp.2008.157396     Document Type: Review

References (42)

1. Anderson NE, Willoughby EW. Chronic meningitis without predisposing illness-a review of 83 cases. Q J Med 1987;63:283-95.
2. Berenguer J, Moreno S, Laguna F, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992;326:668-72.
3. Kumar R, Singh SN, Kohli N. A diagnostic rule for tuberculous meningitis. Arch Dis Child 1999;61:221-4.
4. Thwaites GE, Chau TT, Stepniewska K, et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002;360:1287-92.
5. Kalita J, Misra UK. Outcome of tuberculous meningitis at 6 and 12 months: a multiple regression analysis. Int J Tuberc Lung Dis 1999;3:261-5.
6. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004;351:1741-51.
7. Wohrl S, Geusau A. Neurosylphilis is unlikely in patients with late latent syphilis and a negative blood VDRL test. Acto Derm Venereol 2006;86:335-9.
8. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR 2006;55:22-35.
9. Castro R, Prieto ES, Aguas MJ, et al. Evaluation of the Treponema pallidum particle agglutination technique (TP.PA) in the diagnosis of neurosyphilis. J Clin Lab Anal 2006;20:233-8.
10. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43:1089-134.
11. Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000;30:710-18.
12. Kidd D, Beynon HLC. Neurological complications of systemic sarcoidosis (Review). Sorcoidosis Vasc Diff Lung Dis 2003;20:85-94.
13. Hoitsma E, Faber CG, Drent M, et al. Neurosarcoidosis: a clinical dilemma. Lancet Neurol 2004;3:397-407.
14. Aszkanazy CL. Sarcoidosis of the central nervous sytem. J Neuropathol Exp Neurol 1952;11:392-400.
15. O'Sullivan E, Graham EM. Retinal diseases. In: Schapira AHV, ed. Neurology and clinical neuroscience. Philadelphia: Mosby Elsevier, 2007:295-6.
16. Edelsten C, Pearson A, Jaynes E, et al. The ocular and systemic prognosis of patients presenting with sarcoid uveitis. Eye 1999; 13:748-53.
17. Steiger MJ, Tarnesbury G, Gabe S, et al. Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol 1993;33:407-11.
18. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, et al. Uveitis in Behçet's disease: an analysis of 880 patients. Am J Ophthalmol 2004;138:373-80.
19. Serdaroglu P, Yazici H, Ozdemir C, et al. Neurologic involvement in Behçet's syndrome. Arch Neurol 1989;46:265-9.
20. Kidd D, Steuer A, Denman AM, et al. Neurological complications of Behçet's syndrome. Brain 1999;122:2183-94.
21. Akman-Demir G, Serdaroglu P, Tasci B, et al. Clinical patterns of neurological involvement in Behçet's disease. Brain 1999; 122:2171-81.
22. Siva A, Kantarci OH, Saip S, et al. Behçet's disease: diagnosis and prognostic aspects of neurological involvement. J Neurol 2001;248:95-103.
23. Nishino H, Rubino FA, DeRemee RA, et al. Neurologic involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993;33:4-9.
24. Yokoyama A, Ohta K, Kojima H, et al. Vogt-Koyanagi-Harada disease masquerading anterior ischaemic optic neuropathy. Br J Ophthalmol 1999;83:123.
25. Lubin JR, Loewenstein JI, Frederick AR Jr. Vogt-Koyanagi-Harada syndrome with focal neurologic signs. Am J Ophthalmol 1981; 91:332-41.
26. Touitou V, Escande C, Bodaghi B, et al. Prise en charge diagnostique et therapeutique du syndrome de Vogt-Koyanagi-Harada. J Fr Ophtalmol 2005;28:9-16.
27. Brazis PW, Stewart M, Lee AG. The uveo-meningeal syndromes. The Neurologist 2004;10:171-84.
28. Ikeda K, Suzuki S, Ichijo M, et al. How high is high in steroid treatment of Vogt-Koyanagi-Harada syndrome? Neurology 1997; 48:537.
29. Hietaharju A, Jantti V, Korpela M, et al. Nervous system involvement in systemic lupus erythematosus, Sjogren syndrome and scleroderma. Acta Neurol Scand 1993;88:299-308.
30. Delalande S, de Seze J, Fauchais AL, et al. Neurological manifestations in primary Sjogren's syndrome. A study of 82 cases. Medicine 2004;83:280-91.
31. Lancman ME, Mesropian H, Granillo RJ. Chronic aseptic meningitis in a patient with systemic lupus erythematosus. Can J Neurol Sci 1989;16:354-6.
32. Hung JJ, Ou LS, Huang JL. Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol 2005; 32:40-3.
33. Kupersmith MJ, Martin V, Heller G, et al. Idiopathic hypertrophic pachymeningitis. Neurology 2004;62:686-94.
34. Goyal M, Malik A, Mishra NK, et al. Idiopathic hypertrophic pachymeningitis: spectrum of the disease. Neurorad 1997; 39:619-23.
35. Moris G, Garcia-Manco JC. The challenge of drug-induced aseptic meningitis. Arch Intern Med 1999;159:1185-94.
36. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med 1994;121:259-62.
37. Jolles S, Sewell WA, Leighton C. Drug-induced meningitis: diagnosis and management. Drug Saf 2000;22:215-26.
38. Kashiyama JL, Valacer D, Cunningham-Rundles C, et al. A multi-center randomised, double blind placebo controlled trial of high dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin Immunol 1999;91:126-33.
39. Gleissner B, Chamberlain MC. Neoplastic meningitis. Lancet Neurol 2006;5:443-52.
40. Chowdhary S, Chamberlain M. Leptomeningeal metastases: current concepts and management guidelines. JNCCN 2005;3:693-703.
41. Ginsberg L. Difficult and recurrent meningitis. J Neurol Neurosurg Psychiatry 2004;75(Suppl I):116-121.
42. Tedder DG, Ashley R, Tyler KL, et al. Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann Intern Med 1994;121:334-8.